Precigen, Inc. (PGEN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.10-0.56%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PGEN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | — | 9.7 | — | 6.2 | 26.9 | 14.3 | 32.0 | 90.7 | 151.2 | 231.0 | 190.9 | 173.6 | 71.9 | 23.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 231.0 | 190.9 | 173.6 | 71.9 | 23.8 |
| Operating Expenses & Income | ||||||||||||||
| Selling, General & Admin | — | 70.1 | — | 40.4 | — | — | — | — | 137.8 | 146.1 | 142.3 | 109.1 | 63.6 | — |
| R&D Expenses | — | 41.3 | — | 48.6 | — | — | — | — | 404.6 | 143.2 | 112.1 | 147.5 | 59.0 | 48.1 |
| Operating Income | — | (110.5) | — | (99.8) | (80.0) | (111.0) | (104.5) | (171.3) | (505.6) | (137.9) | (125.2) | (146.9) | (70.0) | (58.0) |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | 3.9 | — | — | — | — | — | — | 8.5 | 0.6 | 0.9 | 1.2 | 0.7 | 0.1 |
| Interest & Investment Income | — | 3.2 | — | 3.2 | — | — | — | — | 19.1 | 19.5 | 10.2 | 1.9 | 0.8 | 0.2 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | (10.6) | (18.9) | (9.3) | (0.6) | (0.1) | (0.0) |
| Other Non-Operating Income / Expenses | — | (140.1) | — | 3.4 | — | — | — | — | (19.0) | 22.5 | (47.9) | 68.8 | (10.5) | 17.7 |
| Asset Writedown | — | — | — | — | — | — | — | 120.5 | 60.5 | 16.8 | — | — | — | — |
| EBT, Incl. Unusual Items | — | (250.6) | (128.0) | (96.4) | (80.0) | (111.0) | (104.5) | (171.3) | (395.9) | (78.4) | (194.2) | (87.0) | (85.7) | — |
| Income Tax Expense | — | 0.0 | (1.8) | (0.5) | (0.2) | (0.2) | (0.1) | (0.9) | (15.4) | 2.1 | (3.9) | 1.0 | (0.1) | 0.0 |
| Net Income | ||||||||||||||
| Minority Interest | — | — | — | — | — | 0.0 | 0.0 | (1.6) | (5.4) | (9.8) | (3.7) | (3.5) | (3.8) | (1.9) |
| Net Income | (157.7) | (250.6) | (126.2) | (95.9) | 28.3 | (92.2) | (170.5) | (322.3) | (509.3) | (117.0) | (186.6) | (84.5) | (81.8) | (39.0) |
| Per Share | ||||||||||||||
| Basic EPS | (0.44) | (1.37) | (0.47) | (0.39) | 0.14 | (0.47) | (1.02) | — | — | — | — | — | — | — |
| Diluted EPS | (0.38) | (1.37) | (0.47) | (0.39) | 0.14 | (0.47) | (1.02) | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 356.9 | 313.0 | 267.7 | 244.5 | 200.4 | 197.8 | 167.1 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 413.7 | 313.0 | 267.7 | 244.5 | 200.4 | 197.8 | 167.1 | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||
| EBITDA | — | (107.3) | — | (93.1) | (69.2) | (97.2) | (87.0) | (146.4) | (472.5) | (106.7) | (100.6) | (129.1) | (59.5) | (50.8) |
| EBIT | — | (110.5) | — | (99.8) | (80.0) | (111.0) | (104.5) | (171.3) | (505.6) | (137.9) | (125.2) | (146.9) | (70.0) | (58.0) |
| Effective Tax Rate | — | — | — | 0.5% | 0.2% | 0.1% | 0.1% | 0.5% | 3.9% | -2.6% | 2.0% | -1.2% | 0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.